IsoRay, Inc. (ISR) Radiation Technology used in World’s First Treatment of Metastasized Brain Cancer
Medical technology company IsoRay today announced that doctors at New York Presbyterian Hospital/ Weill Cornell Medical Center have performed the world's first treatment of metastasized brain cancer using IsoRay's Cesium-131 brachytherapy (internal radiation therapy) seeds, which previously received FDA clearance for the treatment of various cancers. Treatment of metastasized cancers, which are cancers that spread from the site of the original tumor, is IsoRay's latest application of pioneering brachytherapy treatment, representing milestone advancement in internal radiation therapy. Doctors at the Medical Center implanted the seeds directly into a woman's brain to treat a cancer that had originated in the breast.…